Your session is about to expire
← Back to Search
Gabapentin for Postoperative Pain After Rhinoplasty
Study Summary
This trial found that adding gabapentin to the standard pain regimen for people undergoing rhinoplasty reduced postoperative opioid consumption within the first 72 hours.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am scheduled for a nose job with general anesthesia.I regularly use opioids for a medical condition or have taken them within 48 hours before surgery.I have a history of liver disease.You have had problems with alcohol or drug abuse in the last 6 months.I have used gabapentin or pregabalin in the last 14 days.I can read and have signed the consent form in English.I am not allergic to acetaminophen, gabapentin, or opioids.I am 18 years old or older.I have a history of autoimmune or neurodegenerative disease.I have taken acetaminophen in the week before my surgery.
- Group 1: Gabapentin
- Group 2: Placebo
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Gabapentin obtained the necessary authorization from the FDA?
"Due to the Phase 1 nature of this clinical trial, our internal assessment of Gabapentin's safety is rated at a 1. This rating takes into account limited data surrounding both efficacy and safety."
Are there still openings available for individuals to join this clinical experiment?
"Clinicaltrials.gov reflects that this medical trial is still searching for participants, having first been posted on January 30th 2018 and last updated on September 23rd 2021."
What conditions are ameliorated by prescribed Gabapentin?
"Gabapentin is an efficacious remedy for managing neuralgia, epilepsies, and postherpetic neuralgia."
Are there any historical precedents of Gabapentin being used in a research setting?
"At the moment, 25 medical trials are currently underway for Gabapentin with 9 studies in their final testing phase. The bulk of these tests take place in Columbus, Ohio; however, 67 other locations across America are also running trials on this medication."
How many people have joined the experiment thus far?
"Affirmative. According to information present on clinicaltrials.gov, this research project is presently accepting subjects into the study. It was initially posted on 30th January 2018 and last revised on 23rd September 2021; 64 individuals are required from a single medical facility for enrolment in this trial."
Share this study with friends
Copy Link
Messenger